BCL7A and primary cutaneous T-cell non-Hodgkin lymphoma: By screening differential methylation between 28 patients with primary cutaneous T-cell lymphoma (CTCL) and benign T-cell samples, BCL7A demonstrated a higher frequency of hypermethylated.